First Merchants vs Trustmark
FRME and TRMK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FRME and TRMK compare
First Merchants and Trustmark are about the same size, with market caps of $2.6B and $2.6B.
On earnings, Trustmark is cheaper: it trades at 11.4× trailing earnings, against 12.7× for First Merchants.
First Merchants grew revenue faster over the last twelve months (8.5% versus 3.8% for Trustmark).
Trustmark keeps more of each dollar of sales as profit, with a net margin of 28.6% compared with 27.3% at First Merchants.
Both pay dividends: First Merchants yields 3.6% and Trustmark 2.2%.
Trustmark scores higher on the StockData Score (15 against 11 for First Merchants), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FRME | TRMK |
|---|---|---|
| Size and price | ||
| Market cap | $2.6B | $2.6B |
| Share price | $41.07 | $45.56 |
| Change, 1 year | 13.4% | 18.9% |
| Change, 5 years | −1.3% | 39.2% |
| Beta (5Y) | 0.68 | 0.68 |
| Employees | 2,086 | 2,543 |
| StockData Score | ||
| Total score | 11 | 15 (better) |
| Valuation score | 3 | 5 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 12.7× | 11.4× (better) |
| P/S | 3.6× | 3.2× (better) |
| P/B | 1.0× (better) | 1.3× |
| P/FCF | – | 10.2× |
| PEG | 20.89 | 0.24 (better) |
| FCF yield | – | 9.8% |
| Fair value | $42.00 | $45.64 |
| Margin of safety | 2.2% (better) | 0.17% |
| Growth | ||
| Revenue growth (TTM) | 8.5% (better) | 3.8% |
| Revenue growth, 5Y average | 6.1% (better) | 2.7% |
| Net income growth (TTM) | −15.3% | 5.8% (better) |
| EPS growth (TTM) | −19.3% | 9.3% (better) |
| EPS growth, 5Y average | 7.2% | 8.1% (better) |
| Profitability | ||
| Net margin | 27.3% | 28.6% (better) |
| FCF margin | – | 31.5% |
| Return on equity | 7.8% | 11.2% (better) |
| Financial health | ||
| Altman Z-score | 0.22 | 0.30 (better) |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 3.6% (better) | 2.2% |
| Payout ratio | 45.6% | 24.9% |
| Years of dividend growth | 14 (better) | 1 |
| Dividend growth, 5Y average | 6.6% (better) | 0.85% |
| Buyback yield | 2.4% | 3.9% (better) |
| Shareholder yield | 5.9% | 6.1% (better) |
| Ownership | ||
| Held by institutions | 74.5% | 80.7% |
| Held by insiders | 2.2% | 1.9% |
| Insider net buying, 12 months | −$1.7M | −$24.2K (better) |
| Short interest, % of float | – | 6.0% |
Go deeper
- FRME stock overview
- FRME income statement
- FRME valuation and score
- TRMK stock overview
- TRMK income statement
- TRMK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.